Inflammation | Xconomy

by in

Entry	Blogger	Date ▴	Location
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs	Luke Timmerman	01/06/09	Seattle
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes	Ryan McBride	12/18/08	Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010	Luke Timmerman	08/05/08	Seattle
Page 1 of 1